AAVantgarde also received continued strong support from existing investors Longwood Fund and Sofinnova Partners. The proceeds from the financing will support: Completion of clinical PoC of AAVantgarde ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback